Mounjaro Kwikpen 10mg Pre-Filled Pen 0.6ml - 4 Doses

Mounjaro (tirzepatide) 10mg is a prescription medication used to manage blood sugar levels in adults with type 2 diabetes. This once-weekly injectable treatment works by activating two key hormone receptors, GLP-1 and GIP. This dual action helps your body improve its natural insulin response after meals, decreases the amount of sugar produced by the liver, and slows down how quickly food is digested. As a result, Mounjaro effectively lowers blood sugar levels and HbA1c, a crucial marker of long-term glycemic control.

The 10mg dose is an important step in the treatment escalation plan, designed to help patients who need a higher dosage to reach their blood sugar targets, in combination with a healthy diet and exercise regimen.

• Enhanced Blood Sugar Control: Provides significant support in reducing and maintaining stable blood glucose levels.
• Effective HbA1c Reduction: Clinically proven to help patients achieve a lower HbA1c, indicating improved long-term management.
• Dual GIP and GLP-1 Action: Its unique mechanism offers a comprehensive approach to managing type 2 diabetes.
• Convenient Once-Weekly Injection: The pre-filled KwikPen is designed for easy and simple self-administration.
• Supports Weight Management: Clinical studies have shown that Mounjaro can also contribute to weight loss, which is often a goal for people with type 2 diabetes

• Use Mounjaro exactly as prescribed by your doctor and follow all directions on your prescription label
• Preparation: Remove the pen from refrigerator. Leave the gray base cap on until you are ready to inject. Wipe your skin with a swab and let the injection site dry before you inject your dose. Pull off the gray base cap. Make sure the pen is locked. Do not unlock the Pen until you place the clear base on your skin and are ready to inject. Pull the gray base cap straight off and throw it away in your household trash. Insert the needle (needle sold separately, not included in this pack). Place the clear base flat against your skin at the injection. Do not mix insulin and Mounjaro together in the same injection.
• Dose Escalation: The 10mg dose is typically prescribed after you have completed at least four weeks of treatment on the 7.5mg dose. Your doctor will determine if this is the right next step for your treatment plan.
• Important Warnings: Hypoglycemia - When used with other diabetes medicines, Mounjaro may cause low blood sugar.
• FDA Boxed Warning: Mounjaro carries a serious warning regarding the potential risk of thyroid C-cell tumors, including Medullary Thyroid Carcinoma (MTC). Do not use this medication if you or a family member have a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Common Side Effects: The most common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, and stomach pain. These often lessen over time as your body adjusts.
• Serious Side Effects: Seek immediate medical attention if you experience symptoms of pancreatitis (severe stomach pain), severe allergic reaction, or gallbladder issues.
• Disclaimer: This product description is for informational purposes only and is not a substitute for professional medical advice. The details provided are based on the manufacturer's information. Always consult your doctor or a pharmacist for personalized advice, and read the full package insert before using the product.